Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in NGS - Virtual Event

Mark Caulfield's Biography

Mark Caulfield, Chief Scientist, Queen Mary University of London

Mark graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital (Barts) where he developed a research programme in molecular genetics of hypertension and clinical research. In 2009 he won the Lily Prize of the British Pharmacology Society.
In 2000 Mark successfully bid for £3.1m to create the Barts and The London Genome Centre at QMUL, underpinning over 40 programmes of research. Since 2008 he has directed the Barts National Institute of Health Research (NIHR) Cardiovascular Biomedical Research Unit. In 2012 he become Co-Chair of NIHR Comprehensive Research Network Cardiovascular Sub-Speciality Group.
Mark was appointed Director of the William Harvey Research Institute in 2002 and was elected to the Academy of Medical Sciences in 2008. Particular areas of research are Cardiovascular Genomics and Translational Cardiovascular Research and Pharmacology.
From 2009 to 2011 Mark was President of the BHS. He also served on the NICE Guideline Group for hypertension and leads the Joint UK Societies’ Working Group and Consensus on Renal Denervation.
In 2013 he became an NIHR Senior Investigator and was appointed as the Chief Scientist for Genomics England (NHS 100K Sequencing Project) 2013-2017.

Mark Caulfield Image

The 100,000 Whole Genome Sequencing Project

Tuesday, 5 May 2015 at 11:00

Add to Calendar ▼2015-05-05 11:00:002015-05-05 12:00:00Europe/LondonThe 100,000 Whole Genome Sequencing ProjectAdvances in NGS - Virtual Event in Virtual EventVirtual

The National Health Service has recognised the transformative potential for healthcare of the genetic variation within our DNA. The sequencing of 100,000 whole genomes from people with rare disease, cancer and infectious disease linked into their electronic medical records is designed to create a life course refreshable dataset that will transform the capability and capacity to apply Genomic Medicine in patient care. This will provide new opportunities for diagnosis and prime new therapeutic advances. It may produce new uses for old medicines and enable us to stratify patient response, getting the right treatment to the right patient offering opportunities for those afflicted by diseases which disable and shorten lives.

Add to Calendar ▼2015-05-05 00:00:002015-05-06 00:00:00Europe/LondonAdvances in NGS - Virtual EventAdvances in NGS - Virtual Event in Virtual EventVirtual